|Articles|September 1, 2020
COVID-19: A Catalyst for Technological Change in Clinical Research
Author(s)Elligo
Decentralized or hybrid trial models have not been widely adopted in clinical research until now. See how COVID-19 is ushering in a new era of clinical research.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: Local-First Communication Design, RBQM Financial Impact, and First Oral PCSK9 Inhibitor
2
Patient Recruitment in Clinical Trials: Why the Industry's Longstanding Approach Is No Longer Fit for Purpose
3
Applying Systems Thinking to the Future of Clinical R&D
4
FDA Finalizes Guidance on Clinical Trial Design for Psychedelic Drug Development
5